Published in Immunology on December 01, 1986
The influence of FK-506 on the thymus: an immunophenotypic and structural analysis. Immunology (1990) 1.03
Immunosuppression with cyclosporin A alters the thymic microenvironment. Clin Exp Immunol (1989) 0.94
Acquisition of cell-mediated immunity to Leishmania. I. Primary T-cell activation detected by IL-2 receptor expression. Immunology (1987) 0.89
Activated rat T cells synthesize and express functional major histocompatibility class II antigens. Immunology (1995) 0.82
Glucocorticoids induce the expression of CD8 alpha chains on concanavalin A-activated rat CD4+ T cells: induction is inhibited by rat recombinant interleukin 4. J Exp Med (1992) 0.81
Phenotypic analysis of peripheral CD4+ CD8+ T cells in the rat. Immunology (2000) 0.80
BB-DR/Edinburgh: a lymphopenic, non-diabetic subline of BB rats. Immunology (1993) 0.79
Quantification of proliferating lymphocyte subsets appearing in the intestinal lymph and the blood. Clin Exp Immunol (1999) 0.79
Recirculation of lymphocyte subsets (CD5+, CD4+, CD8+, SBU-T19+ and B cells) through gut and peripheral lymph nodes. Immunology (1989) 0.77
An immunohistochemical analysis of T cells in primary B cell malignant lymphoma of the brain. Acta Neuropathol (1989) 0.75
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
"Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A (1978) 17.69
The differentiation and function of human T lymphocytes. Cell (1980) 11.88
The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology (1985) 7.77
Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci U S A (1982) 5.85
Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med (1978) 4.51
Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med (1979) 3.76
Functions of rat T-lymphocyte subsets isolated by means of monoclonal antibodies. Immunol Rev (1983) 3.70
Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol (1978) 3.36
Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity. J Exp Med (1978) 3.18
Significance of Lyt phenotypes: Lyt2 antibodies block activities of T cells that recognize class 1 major histocompatibility complex antigens regardless of their function. Proc Natl Acad Sci U S A (1981) 2.95
Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin. J Immunol (1981) 2.26
Specific binding of alloantigens to T cells activated in the mixed lymphocyte reaction. J Exp Med (1976) 2.04
Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J Immunol (1985) 1.93
Alloactivated Lyt 1 +2- T lymphoblasts bind syngeneic Ia antigens. Nature (1980) 0.88
A novel cell type carrying both Th and Tc/s markers in the blood of cyclosporine-treated, allografted rats. Transplantation (1985) 0.84
Demonstration of the stability of the membrane phenotype of T helper cells after priming and boosting with a hapten-carrier conjugate. Eur J Immunol (1983) 0.82
Detection of Ia alloantigens on phytohemagglutinin-stimulated T blast cells. Transplantation (1981) 0.80
Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease. Nature (1981) 2.71
Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritic responses mediated by active peripheral suppression. Autoimmunity (1993) 0.96
The effects of cyclosporin on lymphocyte activation in a systemic graft-vs.-host reaction. Eur J Immunol (1985) 0.90
Cell damage resulting from the labeling of rat lymphocytes and HeLa S3 cells with In-111 oxine. J Nucl Med (1979) 0.89
The pharmacokinetics of anti-thymocyte globulin (ATG) following intravenous infusion in man. Clin Nephrol (1996) 0.85
A comparison of immune responses against AG-B and non-AG-B antigens, presented alone or together. Transplantation (1977) 0.84
Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation. Lancet (1996) 0.82
Use of monoclonal antibodies to quantitate T lymphocyte subpopulations in human cardiac allografts. Transplantation (1984) 0.80
The kinetics and specificity of lymphocyte infiltration of cardiac allografts in unmodified and cyclosporin-treated rats. Transplantation (1984) 0.78
T cell activation in the presence of cyclosporine in three in vivo allograft models. Transplantation (1988) 0.78
Mechanism of action of cyclosporine in preventing cardiac allograft rejection. I. Rate of entry of lymphocytes from the blood, fibrin deposition, and expression of Ia antigens on infiltrating cells. Transplantation (1987) 0.76
Selection of antigen-specific cells by adherence to allogeneic cell monolayers: cytolytic activity, graft-vs.-host activity and numbers of adherent and nonadherent cells. Eur J Immunol (1978) 0.76
Mechanism of action of cyclosporine in preventing cardiac allograft rejection. II. Graft tissue levels of prostacyclin and thromboxane. Transplantation (1987) 0.75
5-year follow-up of patients successfully transplanted after immunoadsorption to remove anti-HLA antibodies. Nephron (1996) 0.75
The specificity of ongoing immune responses against histocompatibility antigens investigated by adhesion of responding cells to lymphocyte monolayers. Transplant Proc (1979) 0.75
In vivo imaging of rat lymphocytes with an indium 111-labelled anti-T cell monoclonal antibody: a comparison with indium 111-labelled lymphocytes. Eur J Nucl Med (1990) 0.75
Targeting of lymphocytes with 111In-labelled monoclonal antibodies. Nucl Med Commun (1988) 0.75
Successful treatment of accelerated vascular rejection in a highly immunised renal transplant recipient with immunoadsorption and 15-deoxyspergualin. Transpl Int (2004) 0.75